AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

DynCorp enters phase I smallpox vaccine clinical trial.(Brief Article)

Vaccine Weekly

| May 29, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 MAY 29 - (NewsRx.com & NewsRx.net) -- DynPort Vaccine Company LLC (DVC), a joint venture between DynCorp of Reston, Virginia, and Porton International, Inc., announced that it will enter into a large phase I clinical trial consisting of approximately 150 volunteers for a new smallpox vaccine.

DVC's trial is the largest study conducted to date that compares a smallpox vaccine, developed through state-of-the-art large-scale cell culture technology, to the previously licensed vaccine (Dryvax), which is currently in limited supply.

The phase I trial will be conducted at the University of Kentucky Chandler Medical Center. Students at the university and adults living in the Lexington area who have not been previously vaccinated will be recruited. The study will evaluate tolerability, safety, and immunogenicity of DVC's new vaccine as compared with Dryvax. DVC's vaccine is being developed for the Department of Defense (DoD) through the Joint Vaccine Acquisition Program (JVAP) and is a derivative of the U.S. Army's strain previously tested by the DoD in small subject ...

Related articles from newspapers, magazines, journals, and more
DynCorp Company Enters Phase I Smallpox Vaccine Clinical Trial; Trial to Be...
Press release article from: PR Newswire April 26, 2002 700+ words
...large Phase I clinical trial consisting...volunteers for a new smallpox vaccine. DVC's trial...compares a smallpox vaccine, developed...that if this clinical trial proves successful...specific smallpox vaccine experience...
Therion Biologics and the National Institute of Allergy and Infectious...
Press release article from: PR Newswire December 19, 2002 700+ words
...initiated a Phase I clinical trial of TBC-MVA...s preventive smallpox vaccine. Therion derived...currently available smallpox vaccine, Dryvax(R...is the first clinical trial in the United...Germany as a smallpox vaccine. In 1958 CVA...This Phase I ...
CSC Joint Venture DynPort Completes Phase I Smallpox Vaccine Clinical Trial.
Press release article from: PR Newswire April 17, 2003 700+ words
...immunogenicity of an improved cell-cultured smallpox vaccine (CCSV). In this trial, 100% of...the historic calf lymph-produced smallpox vaccine (Dryvax(R)). However, the incidence...adequate stocks of effective and safe smallpox vaccine that meets modern manufacturing standards...
VaxGen to Present Interim Results of Phase I/II Clinical Trial of Smallpox...
Press release article from: PR Newswire March 8, 2005 700+ words
...of Kentucky College of Medicine, and a Principal Investigator of the Phase I/II clinical trial of LC16m8, will present data on VaxGen's smallpox vaccine candidate at the 2005 ASM Biodefense Conference on March 21, 2005 at the Baltimore...
A phase II study on immunogenicity and safety of MVA-BN[R] (IMVAMUNE[TM])...
Magazine article from: Journal of Drugs in Dermatology July 1, 2006 700+ words
...Infectious Diseases (NIAID). The purpose of this study is to compare the immunogenicity and safety of an investigational smallpox vaccine in subjects with atopic dermatitis to healthy volunteers. Condition Intervention Phase Atopic Dermatitis Vaccine: MVA...
OraVax in $343 Million Contract to Develop Smallpox Vaccine for...
Newspaper article from: Knight Ridder/Tribune Business News Rosenberg, Ronald September 21, 2000 700+ words
...deliveries of the smallpox vaccine, which has a five...batches of an old smallpox vaccine that was first developed...part of the pivotal clinical trial, said Gordon. The initial batches of the smallpox vaccine will be made by BioReliance...
VaxGen Begins Clinical Development of its Attenuated Smallpox Vaccine Candidate.
Press release article from: PR Newswire October 20, 2004 700+ words
...Phase I/II clinical trial to evaluate...attenuated smallpox vaccine candidate...attenuated smallpox vaccine for use in...Phase I/II Clinical Trial of LC16m8 The...attenuated smallpox vaccine and to license...
National Institute of Allergy and Infectious Diseases Study Results Support...
News wire article from: Ascribe Higher Education News Service March 28, 2002 700+ words
...results from a key clinical trial indicate that the...S. supply of smallpox vaccine -- 15.4 million...our stockpile of smallpox vaccine can be expanded...Expanding the U.S. smallpox vaccine supply has been...
For more facts and information, see all results

Source: HighBeam Research, DynCorp enters phase I smallpox vaccine clinical trial.(Brief Article)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA